Stock Scorecard



Stock Summary for Tenax Therapeutics Inc (TENX) - $1.61 as of 11/13/2026 10:34:18 AM EST

Total Score

10 out of 30

Safety Score

40 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for TENX

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for TENX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for TENX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for TENX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for TENX (40 out of 100)

Stock Price Rating (Max of 10) 2
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 8
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 8
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for TENX

TENX Investor Alert: Johnson Fistel Encourages Tenax 11/12/2026 3:40:00 PM
TENX Deadline Alert: SueWallSt Reminds Tenax Therapeutics, Inc. (TENX) Investors of Securities Class Action Deadline on December 28, 2026 11/12/2026 3:10:00 PM
Warrants for 447,537 shares feature in Adage's amended Tenax Therapeutics (TENX) stake report. 11/12/2026 1:41:00 PM
TENX UPCOMING DEADLINE: Levi & Korsinsky Alerts Tenax Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm 11/11/2026 5:10:00 PM
Deadline Alert: Tenax Therapeutics, Inc. Investors Have 11/11/2026 2:20:00 PM
What's Next for Tenax Therapeutics, Inc. Shareholders After 89.77% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline 11/10/2026 6:42:00 PM
Tenax Therapeutics, Inc. (TENX) Stock Price, News, Quote & History 11/10/2026 3:12:00 PM
TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law 11/10/2026 10:25:00 AM
INVESTOR DEADLINE: Tenax Therapeutics, Inc. (TENX) Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 28, 2026 Deadline 11/9/2026 2:32:00 PM
TENX DEADLINE: Levi & Korsinsky Reminds Tenax Therapeutics, 11/9/2026 10:15:00 AM

Financial Details for TENX

Company Overview

Ticker TENX
Company Name Tenax Therapeutics Inc
Country USA
Description Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing, and marketing products for cardiovascular and pulmonary disease in the United States and Canada. The company is headquartered in Morrisville, North Carolina.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 9/30/2026
Next Earnings Date N/A

Stock Price History

Last Day Price 1.61
Price 4 Years Ago 178.24
Last Day Price Updated 11/13/2026 10:34:18 AM EST
Last Day Volume 896,950
Average Daily Volume 1,827,141
52-Week High 19.40
52-Week Low 1.31
Last Price to 52 Week Low 22.90%

Valuation Measures

Trailing PE N/A
Industry PE 61.26
Sector PE 70.87
5-Year Average PE -2.63
Free Cash Flow Ratio 0.64
Industry Free Cash Flow Ratio 21.91
Sector Free Cash Flow Ratio 34.06
Current Ratio Most Recent Quarter 14.01
Total Cash Per Share 2.50
Book Value Per Share Most Recent Quarter 2.03
Price to Book Ratio 0.71
Industry Price to Book Ratio 84.24
Sector Price to Book Ratio 28.66
Price to Sales Ratio Twelve Trailing Months 414.72
Industry Price to Sales Ratio Twelve Trailing Months 20.46
Sector Price to Sales Ratio Twelve Trailing Months 19.65
Analyst Buy Ratings 5
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 45,536,400
Market Capitalization 73,313,604
Institutional Ownership 86.39%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 3.39%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -198.82%
Reported EPS 12 Trailing Months -1.39
Reported EPS Past Year -1.01
Reported EPS Prior Year -1.33
Net Income Twelve Trailing Months -65,763,000
Net Income Past Year -52,599,000
Net Income Prior Year -17,602,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%
Operating Margin Twelve Trailing Months 0.00%

Balance Sheet

Total Cash Most Recent Quarter 113,729,000
Total Cash Past Year 97,565,000
Total Cash Prior Year 94,851,000
Net Cash Position Most Recent Quarter 113,450,198
Net Cash Position Past Year 97,064,097
Long Term Debt Past Year 500,903
Long Term Debt Prior Year 624,302
Total Debt Most Recent Quarter 278,802
Equity to Debt Ratio Past Year 0.99
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 97,071,000
Total Stockholder Equity Prior Year 91,993,000
Total Stockholder Equity Most Recent Quarter 108,659,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -49,353,000
Free Cash Flow Per Share Twelve Trailing Months -1.08
Free Cash Flow Past Year -35,800,000
Free Cash Flow Prior Year -14,811,000

Options

Put/Call Ratio 0.04
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.97
RSI 0.00
50-Day SMA 0.00
150-Day SMA 7.11
200-Day SMA 15.86

System

Modified 11/14/2026 8:32:49 AM EST